Gene · 11167
Papers1,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,795
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Follistatin-like protein 1 attenuates doxorubicin-induced cardiomyopathy by inhibiting MsrB2-mediated mitophagy. | Mol Cell Biochem | 2024 | 38696001 | PubTator, text mining | PubMed |
| Significant Genes Associated with Mortality and Disease Progression in Grade II and III Glioma. | Biomedicines | 2024 | 38672212 | PubTator, text mining | PubMed |
| Exerkine response to acute exercise: Still much to discover. | J Sport Health Sci | 2024 | 38615711 | PubTator, text mining | PubMed |
| THOC7-AS1/OCT1/FSTL1 axis promotes EMT and serves as a therapeutic target in cutaneous squamous cell carcinoma. | J Transl Med | 2024 | 38605354 | PubTator, text mining | PubMed |
| Serum myokines as potential biomarkers of myostatin inhibition in sport doping: a preliminary study on their baseline levels in elite athletes. | Biol Sport | 2024 | 38524822 | PubTator, text mining | PubMed |
| Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA. | J Ethnopharmacol | 2024 | 38518965 | PubTator, text mining | PubMed |
| Label-free quantitative proteomics reveals the mechanisms of Aurora kinase B in renal cell carcinoma. | SAGE Open Med | 2024 | 38516642 | PubTator, text mining | PubMed |
| Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses. | Sci Rep | 2024 | 38499600 | PubTator, text mining | PubMed |
| A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer. | J Cancer Res Clin Oncol | 2024 | 38478111 | PubTator, text mining | PubMed |
| Follistatin-like 1 protects against doxorubicin-induced cardiotoxicity by preventing mitochondrial dysfunction through the SIRT6/Nrf2 signaling pathway. | Cell Biol Int | 2024 | 38436106 | PubTator, text mining | PubMed |
| Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population. | Heart Vessels | 2024 | 38381171 | PubTator, text mining | PubMed |
| FSTL1: A double-edged sword in cancer development. | Gene | 2024 | 38346455 | PubTator, text mining | PubMed |
| FSTL1 Accelerates Nucleus Pulposus Cell Senescence and Intervertebral Disc Degeneration Through TLR4/NF-κB Pathway. | Inflammation | 2024 | 38316670 | PubTator, text mining | PubMed |
| FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer. | Cell Death Dis | 2024 | 38302412 | PubTator, text mining | PubMed |
| Transcriptomic profiling of Dip2a in the neural differentiation of mouse embryonic stem cells. | Comput Struct Biotechnol J | 2024 | 38292475 | PubTator, text mining | PubMed |
| Aseptic loosening around total joint replacement in humans is regulated by miR-1246 and miR-6089 via the Wnt signalling pathway. | J Orthop Surg Res | 2024 | 38287447 | PubTator, text mining | PubMed |
| Analysis of subsets and localization of macrophages in skin lesions and peripheral blood of patients with keloids. | Heliyon | 2024 | 38283250 | PubTator, text mining | PubMed |
| Uncovering Novel Extracellular Matrix Transcriptome Alterations in Lesions of Multiple Sclerosis. | Int J Mol Sci | 2024 | 38279239 | PubTator, text mining | PubMed |
| Interaction between long noncoding RNA and microRNA in lung inflammatory diseases. | Immun Inflamm Dis | 2024 | 38270295 | PubTator, text mining | PubMed |
| Suppression of SPARC Ameliorates Ovalbumin-induced Airway Remodeling via TGFβ1/Smad2 in Chronic Asthma. | Allergy Asthma Immunol Res | 2024 | 38262393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11167/papers?page=8